Is CBMG A Good Stock To Buy Now?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Cellular Biomedicine Group Inc. (CBMG)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% | |
| 2. | Glazer Capital Paul Glazer | 0 | $0 | 0% | |
| 3. | Fairfax Financial Holdings Prem Watsa | 0 | $0 | 0% | |
| 4. | GLG Partners Noam Gottesman | 0 | $0 | 0% | |
| 5. | Pentwater Capital Management Matthew Halbower | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.00 | 4,167 | 29,667 | 2017-12-22 | Filing | ||
| $12.00 | 29,167 | 139,167 | 2017-12-22 | Filing | ||
| $12.00 | 8,333 | 154,090 | 2017-12-22 | Filing | ||
| $6.85 | 2,900 | 129,025 | 2017-06-06 | Filing | ||
| $6.84 | 1,200 | 124,925 | 2017-06-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.08 | 485 | 191,746 | 2019-10-28 | Filing | ||
| $14.68 | 485 | 192,231 | 2019-09-27 | Filing | ||
| $11.47 | 486 | 192,716 | 2019-08-27 | Filing | ||
| $13.70 | 486 | 193,202 | 2019-07-29 | Filing | ||
| $14.94 | 486 | 193,688 | 2019-06-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Hedge Funds Are Warming Up To Cellular Biomedicine Group, Inc. (CBMG)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
This Hedge Fund Bought Cellular Biomedicine Group, Inc. (CBMG) At The Right Time
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through November 22nd.
Cellular Biomedicine Group Inc (CBMG) Expands GMP Capacity For The Growing Chinese Market
Cellular Biomedicine Group Inc (NASDAQ:CBMG) is a developer of proprietary cell therapies for the treatment of cancer and other degenerative diseases, which operates in China.